These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8714536)

  • 1. Combination tissue plasminogen activator and ticlopidine therapy in a rabbit model of acute thromboembolic stroke.
    Bednar MM; Raymond-Russell SJ; Booth CL; Gross CE
    Neurol Res; 1996 Feb; 18(1):45-8. PubMed ID: 8714536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke.
    Bednar MM; Quilley J; Russell SR; Fuller SP; Booth C; Howard D; Gross CE
    Neurosurgery; 1996 Aug; 39(2):352-9. PubMed ID: 8832673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR; Lijnen HR; Stassen JM; Collen D
    Blood; 1991 Jul; 78(1):125-31. PubMed ID: 1906351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator: comparison of dose and route of administration in a rabbit model of thromboembolic stroke.
    Bednar MM; Raymond SJ; Gross CE
    Neurol Res; 1993 Dec; 15(6):405-8. PubMed ID: 7907409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke.
    Gross CE; Raymond SJ; Howard DB; Bednar MM
    Neurosurgery; 1995 Jun; 36(6):1172-7. PubMed ID: 7643999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration.
    Russell D; Madden KP; Clark WM; Zivin JA
    Stroke; 1992 Mar; 23(3):388-93. PubMed ID: 1542901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model.
    Vanderschueren S; Van Vlaenderen I; Collen D
    Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Albers GW; Amarenco P; Easton JD; Sacco RL; Teal P
    Chest; 2008 Jun; 133(6 Suppl):630S-669S. PubMed ID: 18574275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
    Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
    Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
    Bednar MM; Gross CE; Howard DB; Russell SR; Ellenberger C
    Neurol Res; 2001 Oct; 23(7):745-50. PubMed ID: 11680515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide reverses aspirin antagonism of t-PA thrombolysis in a rabbit model of thromboembolic stroke.
    Bednar MM; Gross CE; Howard DB; Russell SR; Thomas GR
    Exp Neurol; 1997 Aug; 146(2):513-7. PubMed ID: 9270062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke?
    Ibrahim MM; Sebastian J; Hussain M; Al-Hussain F; Uchino K; Molina C; Khan K; Demchuk AM; Alexandrov AV; Saqqur M;
    Cerebrovasc Dis; 2010; 30(5):508-13. PubMed ID: 20861622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.